Catheter Ablation of Atrial Fibrillation: Advances and Challenges
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 15 July 2024 | Viewed by 126
Special Issue Editors
Interests: atrial fibrillation; catheter ablation; arrhythmias; cardiac electrophysiology; heart failure; ventricular tachycardia; ventricular fibrillation; sudden cardiac death; cardiac devices
Special Issue Information
Dear Colleagues,
Atrial fibrillation (AF) is the most common heart rhythm disorder in the United States and many other countries across the globe. Numerous groundbreaking technologies and techniques in AF catheter ablation have been developed over the years, allowing it to mature as a durable option for rhythm control. Despite these advances, many gaps regarding the pathophysiology and mechanisms that initiate and sustain AF remain; in turn, these continue to underpin challenges that we encounter in terms of improving outcomes and minimizing complications.
In this Special Issue, we summarize the tremendous progress made in terms of AF catheter ablation and provide a preview of emerging therapies/modalities that are on the horizon. In addition, we highlight the challenges we currently face and opportunities for future growth. Researchers in the field of clinical arrhythmology and electrophysiology are encouraged to submit their findings as original articles or reviews to this Special Issue. Submissions focusing on innovative approaches, novel technologies, and outcomes of clinical studies are particularly encouraged.
Dr. Nicholas Yick Loong Tan
Dr. Christopher V. DeSimone
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atrial fibrillation
- catheter ablation
- pulmonary vein isolation
- cardiac electrophysiology
- cardiac resynchronization therapy
- pulsed field ablation
- hybrid ablation
- non-pulmonary vein triggers
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Pulsed Field Ablation for Pulmonary Vein Isolation in AF Current Status and Future Perspectives: A Single Centre Experience on Redo AF Cases
Abstract: Atrial fibrillation (AF) is the most common sustained arrhythmia and is associated with an increased risk of the development of stroke, heart failure as well as with a deterioration of the quality of life. Regarding the complicity of the initiation and the persistence of AF, the pulmonary vein isolation (PVI) using radiofrequency , cryoenergy or laser has been the most commonly applied procedure. Pulsed Field Ablation (PFA) is a recently introduced method, during which non thermal energy is creating a high voltage current that induces pulses, affecting the myocardiac cell membrane in a selective and tissue specific way. The recent trials evaluated the results of PFA regarding the efficacy of this new method are also discussed.Recent extension of this single shot technique is being carried out to evaluate the potential utility of performing 3-D mapping guided re-do PFA cases. The aim of our paper is to review the current literature data and describe our initial experience using a multipolar PFA catheter for redo AF procedures for recurrent atrial arrhythmias using Rhythmia mapping system and multipolar Orion catheter.
